Skip to main content

Advertisement

Log in

“Evaluation of quality of life in patients with gastric adenocarcinoma receiving chemoradiotherapy: a cross-sectional study”

  • Research
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract  

Purpose

The aim of this study was to evaluate quality of life (QoL) in patients with gastric adenocarcinoma receiving adjuvant chemoradiotherapy (CRT).

Methods

The European Organization for Cancer Research and Treatment Quality of Life Questionnaire-Core 30 (QLQ-C30) and site-specific module for gastric cancer (QLQ-STO22) were administered at four time points to 156 patients admitted to Cumhuriyet University Oncology Center between 2011 and 2018.

Results

The patient group comprised 76% men and 24% women with a median age of 61 years (range, 18–88). During CRT, 12 patients (8%) discontinued treatment, 25 (16%) lost weight, and 42 (27%) had reduced performance. There was significant worsening in QLQ-C30 global health status and all functional and symptom scale scores at CRT completion. These changes were also clinically significant except for physical functioning scores and were supported by minimal clinically important difference measurements. In the QLQ-STO22, all symptoms except dry mouth and hair loss were negatively affected at CRT completion. In general, scores were improved at 1 month after CRT and almost all scores reached baseline level by 6 months. Certain scores were more adversely affected in women (global health status, physical functioning, role functioning, fatigue, pain, and insomnia), those who lost weight during CRT (emotional functioning), and those with CRT interruption (emotional functioning and anxiety).

Conclusion

Although CRT reduces QoL in patients with gastric cancer, the effects tend to resolve within 6 months after completing treatment. Female sex, weight loss, and CRT interruption negatively affected some QoL scores.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Bollschweiler E, Berlth F, Baltin C, Mönig S, Hölscher AH (2014) Treatment of early gastric cancer in the Western world. World J Gastroenterol 20(19):5672–5678. https://doi.org/10.3748/wjg.v20.i19.5672

    Article  PubMed  PubMed Central  Google Scholar 

  2. Gunderson LL, Sosin H (1982) Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys 8:1. https://doi.org/10.1016/0360-3016(82)90377-7

    Article  CAS  PubMed  Google Scholar 

  3. Park SH, Kim DY, Heo JS, Lim DH, Park CK, Lee KW et al (2003) Postoperative chemoradiotherapy for gastric cancer. Ann Oncol 14(9):1373–1377. https://doi.org/10.1093/annonc/mdg366

    Article  CAS  PubMed  Google Scholar 

  4. Park SH, Sohn TS, Lee J, Lim DH, Hong ME, Kim KM et al (2015) Phase III trial to compare adjuvant chemotherapy with capecitabine and cisplatin versus concurrent chemoradiotherapy in gastric cancer: final report of the adjuvant chemoradiotherapy in stomach tumors trial, including survival and subset analyses. J Clin Oncol 33(28):3130–3136. https://doi.org/10.1200/JCO.2014.58.3930

    Article  CAS  PubMed  Google Scholar 

  5. Kassam Z, Mackay H, Buckley CA, Fung S, Pintile M, Kim J, Ringash J (2010) Evaluating the impact on quality of life of chemoradiation in gastric cancer. Curr Oncol 17(4):77–84. https://doi.org/10.3747/co.v17i4.522

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Pruthi DS, Ahmad M, Gupta M, Bansal S, Nautiyal V, Saini S (2018) Assessment of quality of life in resectable gastric cancer patients undergoing chemoradiotherapy as adjuvant treatment. South Asian J Cancer 7(1):16–20. https://doi.org/10.4103/sajc.sajc_196_17

    Article  PubMed  PubMed Central  Google Scholar 

  7. Aaronson NK, Cull AM, Kaasa S, Sprangers MAG (1996) The European Organization of Research and Treatment of Cancer (EORTC) modular approach to quality of life assessment in oncology: and update. In: Spilker B (ed) Quality of Life and Pharmacoeconomics in Clinical Trials, 2nd edn. Raven Press, New York, NY, pp 179–190

    Google Scholar 

  8. Gotay CC, Wilson M (1998) Use of quality-of-life outcome assessments in current cancer clinical trials. Eval Health Prof 21:157–178. https://doi.org/10.1177/016327879802100203

    Article  CAS  PubMed  Google Scholar 

  9. Kaasa S, Bjordal K, Aaronson N, Moum T, Wist E, Hagen S, Kvikstad A (1995) The EORTC core quality of life questionnaire (QLQ-C30): validity and reliability when analysed with patients treated with palliative radiotherapy. Eur J Cancer 31A:2260–2263. https://doi.org/10.1016/0959-8049(95)00296-0

    Article  CAS  PubMed  Google Scholar 

  10. Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire. J Clin Oncol 13:1249–1254. https://doi.org/10.1200/JCO.1995.13.5.1249

    Article  CAS  PubMed  Google Scholar 

  11. Cankurtaran ES, Ozalp E, Soygur H, Ozer S, Akbiyik DI, Bottomley A (2008) Understanding the reliability and validity of the EORTC QLQ-C30 in Turkish cancer patients. Eur J Cancer Care 17(1):98–104. https://doi.org/10.1111/j.1365-2354.2007.00827.x

    Article  CAS  Google Scholar 

  12. Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O et al (2004) Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer 40:2260–2268. https://doi.org/10.1016/j.ejca.2004.05.023

    Article  CAS  PubMed  Google Scholar 

  13. Kim AR, Cho J, Hsu YJ, Choi MG, Noh JH, Sohn TS, Bae JM, Yun YH, Kim S (2012) Changes of quality of life in gastric cancer patients after curative resection: a longitudinal cohort study in Korea. Ann Surg 256(6):1008–1013. https://doi.org/10.1097/SLA.0b013e31827661c9

    Article  PubMed  Google Scholar 

  14. Kobayashi D, Kodera Y, Fujiwara M, Koike M, Nakayama G, Nakao A (2011) Assessment of quality of life after gastrectomy using EORTC QLQ-C30 and STO22. World J Surg 35(2):357–364. https://doi.org/10.1007/s00268-010-0860-2

    Article  PubMed  Google Scholar 

  15. Tyrvainen T, Sand J, Sintonen H, Nordback I (2008) Quality of life in the long-term survivors after total gastrectomy for gastric carcinoma. J Surg Oncol 97:121–124. https://doi.org/10.1002/jso.20925

    Article  PubMed  Google Scholar 

  16. Wu CW, Chiou JM, Ko FS, Lo SS, Chen JH, Lui WY, Wang-Peng J (2008) Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 98:54–59. https://doi.org/10.1038/sj.bjc.6604097

    Article  PubMed  PubMed Central  Google Scholar 

  17. Li J, Liu H, Yang G, Chen S (2018) Quality of life after esophagogastrostomy plus gastrojejunostomy reconstruction following proximal gastrectomy: a comparative study of three surgical procedures. Int J Clin Exp Med 11 (9):9791–9801. www.ijcem.com/ ISSN:1940-5901/IJCEM0056192

  18. Lee MK, Lee KM, Bae JM, Kim S, Kim YW, Ryu KW et al (2008) Employment status and workrelated difficulties in stomach cancer survivors compared with the general population. Br J Cancer 98:708–715. https://doi.org/10.1038/sj.bjc.6604236

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Bae JM, Kim S, Kim YW, Ryu KW, Lee JH, Noh JH et al (2006) Health-related quality of life among disease-free stomach cancer survivors in Korea. Qual Life Res 15:1587–1596. https://doi.org/10.1007/s11136-006-9000-8

    Article  PubMed  Google Scholar 

  20. Amin MB, Edge SB, Greene FL (2017) AJCC cancer staging manual, 8th edn. Springer, New York, NY

    Book  Google Scholar 

  21. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity And Response Criteria Of The Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655

    Article  CAS  PubMed  Google Scholar 

  22. Kondrup J, Rasmussen HH, Hamberg O, Stanga Z (2003) Nutritional risk screening (NRS 2002): a new method based on an analysis of controlled clinical trials. Clin Nutr 22(3):321–336. https://doi.org/10.1016/s0261-5614(02)00214-5

    Article  PubMed  Google Scholar 

  23. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346. https://doi.org/10.1016/0360-3016(95)00060-C

    Article  CAS  PubMed  Google Scholar 

  24. Fayers P, Aaronson NK, Bjordal K, Sullivan M (1995) EORTC QLO-C30 scoring manual. EORTC Data Center, Belgium 8.

  25. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ et al (1993) The European Organization for Research and Treatment of cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376. https://doi.org/10.1093/jnci/85.5.365

    Article  CAS  PubMed  Google Scholar 

  26. Wright A, Hannon J, Hegedus EJ, Kavchak AE (2012) Clinimetrics corner: a closer look at the minimal clinically important difference (MCID). J Man Manip Ther 20(3):160–166. https://doi.org/10.1179/2042618612Y.0000000001

    Article  PubMed  PubMed Central  Google Scholar 

  27. Şeker A (2020) Irrationality of gender inequality and reflections in the public sphere (Toplumsal cinsiyet eşitsizliğinin irrasyonelliği ve kamusal alandaki yansımaları). Curr Res Soc Sci 6(2):92–102. https://doi.org/10.30613/curesosc.651457

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Mukaddes Yılmaz. The first draft of the manuscript was written by Mukaddes Yılmaz and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Mukaddes Yılmaz.

Ethics declarations

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of University of Sivas Cumhuriyet (Date 19.08.2021/No. 2021–08/47).

Conflict of interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yılmaz, M., Erdiş, E., Uçar, M. et al. “Evaluation of quality of life in patients with gastric adenocarcinoma receiving chemoradiotherapy: a cross-sectional study”. Support Care Cancer 31, 600 (2023). https://doi.org/10.1007/s00520-023-08036-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00520-023-08036-3

Keywords

Navigation